Article
Medicine, Research & Experimental
Marina Salmon, Ruth Alvarez-Diaz, Coral Fustero-Torre, Oksana Brehey, Carmen G. Lechuga, Manuel Sanclemente, Fernando Fernandez-Garcia, Alejandra Lopez-Garcia, Maria Carmen Martin-Guijarro, Sandra Rodriguez-Perales, Emily Bousquet-Mur, Lucia Morales-Cacho, Francisca Mulero, Fatima Al-Shahrour, Lola Martinez, Orlando Dominguez, Eduardo Caleiras, Sagrario Ortega, Carmen Guerra, Monica Musteanu, Matthias Drosten, Mariano Barbacid
Summary: KRASG12C inhibitors have greatly improved the clinical management of KRASG12C-mutant lung adenocarcinoma patients, but resistance develops rapidly. In this study, genetically engineered mice were used to compare the efficacy and resistance between genetic ablation and pharmacological inhibition of mutant Kras. Results showed that Kras ablation effectively regressed tumors and prevented resistant cells, while treatment with sotorasib, a selective KRASG12C inhibitor, led to limited antitumor response and rapid onset of resistance. Unlike human tumors, resistance in mice was not due to mutations in RAS signaling pathways, but rather amplification of mutant Kras allele and activation of xenobiotic metabolism pathways.
JOURNAL OF CLINICAL INVESTIGATION
(2023)
Review
Oncology
Miriam Grazia Ferrara, Alessio Stefani, Sara Pilotto, Carmine Carbone, Emanuele Vita, Mariantonietta Di Salvatore, Ettore D'Argento, Ileana Sparagna, Federico Monaca, Giustina Valente, Antonio Vitale, Geny Piro, Lorenzo Belluomini, Michele Milella, Giampaolo Tortora, Emilio Bria
Summary: NSCLC, as a perfect paradigm of precision medicine, shows complex intratumoral heterogeneity and various molecular alterations that profoundly impact the natural history of the disease. The identification of molecular alterations over time has paved the way for biomarker-driven therapy and significantly changed the prognosis of NSCLC patients with oncogene addiction.
FRONTIERS IN ONCOLOGY
(2021)
Article
Cell Biology
Cheng-Yao Chiang, Songqing Fan, Hongmei Zheng, Wenjun Guo, Zehan Zheng, Yihua Sun, Chuanqi Zhong, Juan Zeng, Shuaihu Li, Min Zhang, Tian Xiao, Duo Zheng
Summary: This study reveals the tumor-suppressive role of SETD7 in non-small cell lung cancer (NSCLC) by modulating KRAS methylation and degradation. SETD7 interacts with KRAS and methylates KRAS at lysines 182 and 184, leading to KRAS degradation and attenuation of the RAS/MEK/ERK signaling cascade.
Review
Radiology, Nuclear Medicine & Medical Imaging
Andreas Voskrebenzev, Jens Vogel-Claussen
Summary: Pulmonary proton MRI techniques offer the unique possibility of assessing lung function and structure without the requirement for hyperpolarization or dedicated hardware. Five popular approaches are discussed, with common trends such as free-breathing acquisition, application of UTE to preserve a stronger parenchymal signal, and transition from 2D to 3D acquisition.
JOURNAL OF MAGNETIC RESONANCE IMAGING
(2021)
Article
Gastroenterology & Hepatology
Bruno Bockorny, Andrea J. Bullock, Thomas A. Abrams, Salomao Faintuch, David C. Alsop, S. Nahum Goldberg, Muneeb Ahmed, Rebecca A. Miksad
Summary: The study evaluated the efficacy of short-course sorafenib prior to RFA for HCC tumors and found that sorafenib did not increase the size of the ablation zone achieved with RFA, but significantly decreased tumor blood perfusion. Sorafenib was well-tolerated with no grade 4 toxicity observed. Future research should investigate alternative antiangiogenic strategies to enhance RFA efficacy.
DIGESTIVE DISEASES AND SCIENCES
(2022)
Article
Medicine, General & Internal
Veronica Aran, Mariano Zalis, Tatiane Montella, Carlos Augusto Moreira de Sousa, Bruno L. Ferrari, Carlos Gil Ferreira
Summary: This study investigated the incidence of KRAS mutations and concomitant mutations in advanced non-small cell lung adenocarcinoma patients. Results showed a higher prevalence of male patients, with 20.86% of samples having mutant KRAS and 33.3% of mutant KRAS samples showing other simultaneous mutations. Further research is needed to explore the significance of these genomic alterations in patient prognosis and treatment response.
MEDICINA-LITHUANIA
(2021)
Article
Multidisciplinary Sciences
Xiuqiong Chen, Zhaona Li, Jing Zhou, Qianhui Wei, Xinyue Wang, Richeng Jiang
Summary: This study aimed to explore the association between baseline characteristics of lung cancer patients and the efficacy of immunotherapy. The results showed that age, white blood cell count, lymphocyte count, monocyte count, hemoglobin, lactate dehydrogenase, albumin, and treatment line were significantly associated with progression-free survival (PFS) after immunotherapy. A nomogram based on age, albumin, monocyte count, lactate dehydrogenase, and treatment line was established to predict the prognosis of lung cancer patients receiving immunotherapy.
Article
Radiology, Nuclear Medicine & Medical Imaging
Roberta Fusco, Vincenza Granata, Mario Sansone, Daniela Rega, Paolo Delrio, Fabiana Tatangelo, Carmen Romano, Antonio Avallone, Davide Pupo, Marzia Giordano, Roberto Grassi, Vincenzo Ravo, Biagio Pecori, Antonella Petrillo
Summary: The study demonstrated that the SIS tool showed good accuracy and reliability in evaluating the response to pCRT in patients with locally advanced rectal cancer, effectively identifying major and complete responders to guide surgeons in treatment selection.
Article
Radiology, Nuclear Medicine & Medical Imaging
Oganes Ashikyan, Stanley B. Bradshaw, Nathan J. Dettori, Helena Hwang, Avneesh Chhabra
Summary: This study systematically assessed and described the appearance of synovial sarcomas on MRI, finding that the tumors commonly exhibit heterogeneous appearance, low ADC values, and contrast enhancement. It also noted that peritumoral edema may be absent in such tumors, even in high-grade cases.
Article
Radiology, Nuclear Medicine & Medical Imaging
Wei Wu, Shuchang Zhou, Daniel S. Hippe, Haining Liu, Yujin Wang, Nina A. Mayr, William T. C. Yuh, Liming Xia, Stephen R. Bowen
Summary: The study found that DCE-MRI intensity histogram CoV was significantly associated with malignancy in patients with suspected lung cancer, potentially aiding in the diagnosis of pulmonary lesions and complementing TIC-derived DCE-MRI metrics. Further research is needed to confirm the diagnostic value of DCE-MRI intensity histogram analysis.
ACADEMIC RADIOLOGY
(2021)
Article
Oncology
Ranjan Pathak, Ravi Salgia
Summary: We report a case of near-complete response to first-line pembrolizumab/platinum-doublet regimen in a patient with KRAS/STK11-mutant advanced lung adenocarcinoma. The study highlights that STK11 should not be used to select patients for PD(L)-1 blockade therapy until further prospective validation and clarification of interactions with other biomarkers such as TMB and PD-L1.
CLINICAL LUNG CANCER
(2022)
Article
Biochemistry & Molecular Biology
Sultan Alhayyani, Louise McLeod, Alison C. West, Jesse J. Balic, Christopher Hodges, Liang Yu, Julian A. Smith, Zdenka Prodanovic, Steven Bozinovski, Beena Kumar, Saleela M. Ruwanpura, Mohamed I. Saad, Brendan J. Jenkins
Summary: The oncogenic potential of the STAT3 transcription factor in many human cancers, including lung cancer, is largely attributed to its nuclear activity as a tyrosine-phosphorylated transcription factor. However, an alternate pool of serine-phosphorylated STAT3 in mitochondria has been shown to promote tumorigenesis in a limited number of mutant RAS-addicted neoplasms. In mutant KRAS-driven lung adenocarcinoma, the transcriptional activity of pS(727)-STAT3 is essential for promoting a hyper-proliferative state in cancer cells through metabolic reprogramming.
Article
Radiology, Nuclear Medicine & Medical Imaging
Joseph Cheriyan, Alexandra Roberts, Caleb Roberts, Martin J. Graves, Ilse Patterson, Rhys A. Slough, Rosemary Schroyer, Disala Fernando, Subramanya Kumar, Sarah Lee, Geoffrey J. M. Parker, Lea Sarov-Blat, Carmel McEniery, Jessica Middlemiss, Dennis Sprecher, Robert L. Janiczek
Summary: This study aimed to evaluate lung fluid volume in HF patients using DCE-MRI, finding significantly higher v(e) in HF patients compared to healthy volunteers. The results showed good tolerability of the scanning protocol and repeatability of v(e) in HF patients.
JOURNAL OF MAGNETIC RESONANCE IMAGING
(2022)
Article
Multidisciplinary Sciences
Jean-Philip Daniel Weber, Judith Eva Spiro, Matthias Scheffler, Juergen Wolf, Lucia Nogova, Marc Tittgemeyer, David Maintz, Hendrik Laue, Thorsten Persigehl
Summary: Dynamic contrast enhanced MRI (DCE-MRI) is a useful method for monitoring therapy assessment in lung cancer patients. The repeatability of DCE-MRI needs to be improved for successful clinical use. By measuring the K-trans value, DCE-MRI provides a reliable quantitative biomarker for early non-invasive therapy assessment in lung cancer patients, although there is higher variation in smaller lung lesions.
Article
Biochemistry & Molecular Biology
Anna-Lena Meinhardt, Enkhtsetseg Munkhbaatar, Ulrike Hockendorf, Michelle Dietzen, Marta Dechant, Martina Anton, Anne Jacob, Katja Steiger, Wilko Weichert, Luka Brcic, Nicholas McGranahan, Caterina Branca, Thomas Kaufmann, Michael A. Dengler, Philipp J. Jost
Summary: This study demonstrates the tumor-promoting function of the BOK gene in Kras-driven lung cancer through in vivo experiments in a mouse model.
Article
Oncology
Julius Strauss, Christopher R. Heery, Jeffrey Schlom, Ravi A. Madan, Liang Cao, Zhigang Kang, Elizabeth Lamping, Jennifer L. Marte, Renee N. Donahue, Italia Grenga, Lisa Cordes, Olaf Christensen, Lisa Mahnke, Christoph Helwig, James L. Gulley
CLINICAL CANCER RESEARCH
(2018)
Article
Oncology
Derek Brown, Adriana Zingone, Yunkai Yu, Bin Zhu, Julian Candia, Liang Cao, Brid M. Ryan
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
(2019)
Article
Oncology
Claire L. Meaney, Khadijah A. Mitchell, Adriana Zingone, Derek Brown, Elise Bowman, Yunkai Yu, Angela S. Wenzlaff, Christine Neslund-Dudas, Sharon R. Pine, Liang Cao, Ann G. Schwartz, Brid M. Ryan
JOURNAL OF THORACIC ONCOLOGY
(2019)
Article
Oncology
Alexandra S. Zimmer, Erin Nichols, Ashley Cimino-Mathews, Cody Peer, Liang Cao, Min-Jung Lee, Elise C. Kohn, Christina M. Annunziata, Stanley Lipkowitz, Jane B. Trepel, Rajni Sharma, Lekha Mikkilineni, Margaret Gatti-Mays, William D. Figg, Nicole D. Houston, Jung-Min Lee
JOURNAL FOR IMMUNOTHERAPY OF CANCER
(2019)
Article
Hematology
Sencer Goklemez, Annie P. Im, Liang Cao, Filip Pirsl, Seth M. Steinberg, Lauren M. Curtis, Sandra A. Mitchell, Edward W. Cowen, Judy Baruffaldi, Jeremy Rose, Jacqueline Mays, Alen Ostojic, Noa G. Holtzman, Frances T. Hakim, Steven Z. Pavletic
AMERICAN JOURNAL OF HEMATOLOGY
(2020)
Article
Oncology
Jung-Min Lee, Christina M. Annunziata, John L. Hays, Liang Cao, Peter Choyke, Minshu Yu, Daniel An, Ismail Baris Turkbey, Lori M. Minasian, Seth M. Steinberg, Helen Chen, John Wright, Elise C. Kohn
GYNECOLOGIC ONCOLOGY
(2020)
Article
Oncology
Andrea B. Apolo, Rosa Nadal, Yusuke Tomita, Nicole N. Davarpanah, Lisa M. Cordes, Seth M. Steinberg, Liang Cao, Howard L. Parnes, Rene Costello, Maria J. Merino, Les R. Folio, Liza Lindenberg, Mark Raffeld, Jeffrey Lin, Min-Jung Lee, Sunmin Lee, Sylvia V. Alarcon, Akira Yuno, Nancy A. Dawson, Kimaada Allette, Arpita Roy, Dinuka De Silva, Molly M. Lee, Tristan M. Sissung, William D. Figg, Piyush K. Agarwal, John J. Wright, Yangmin M. Ning, James L. Gulley, William L. Dahut, Donald P. Bottaro, Jane B. Trepel
Article
Hematology
Lauren M. Curtis, Alen Ostojic, David J. Venzon, Noa G. Holtzman, Filip Pirsl, Zoya J. Kuzmina, Kristin Baird, Jeremy J. Rose, Edward W. Cowen, Jacqueline W. Mays, Sandra A. Mitchell, Laura Parsons-Wandell, Galen O. Joe, Leora E. Comis, Ann Berger, Iskra Pusic, Cody J. Peer, William D. Figg, Liang Cao, Robert Peter Gale, Frances T. Hakim, Steven Z. Pavletic
Summary: This study showed that pomalidomide is a safe and effective therapy for steroid-refractory chronic graft-versus-host disease, with particular efficacy in treating sclerotic skin manifestations. The primary endpoint was overall response rate at 6 months and change in body surface area involvement of skin cGVHD, showing promising results in improving the condition of patients with moderate to severe cGVHD.
Article
Biophysics
Sencer Goklemez, Leorey N. Saligan, Filip Pirsl, Noa G. Holtzman, Alen Ostojic, Seth M. Steinberg, Frances T. Hakim, Jeremy J. Rose, Zhigang Kang, Yunkai Yu, Liang Cao, Sandra A. Mitchell, Annie Im, Steven Z. Pavletic
Summary: Limited information is available on the clinical and biological properties of fatigue in patients with chronic graft-versus-host disease (cGvHD). Fatigued patients showed correlations with walk velocity, NIH joint-fascia score, human activity profile, and SF-36 physical and mental health self-report scales. Higher rates of untreated depression and insomnia were reported in the fatigued group, emphasizing the need for clinical management of these conditions.
BONE MARROW TRANSPLANTATION
(2021)
Article
Biochemistry & Molecular Biology
Jessica A. Canter, Sarah E. Ernst, Kristin M. Peters, Bradley A. Carlson, Noelle R. J. Thielman, Lara Grysczyk, Precious Udofe, Yunkai Yu, Liang Cao, Cindy D. Davis, Vadim N. Gladyshev, Dolph L. Hatfield, Petra A. Tsuji
Summary: The study suggests that Selenof may play a significant role in the development of colon tumors, affecting intestinal barrier integrity and the structural changes in glandular and mucin-producing goblet cells.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2021)
Article
Multidisciplinary Sciences
Yunkai Yu, Dominic Esposito, Zhigang Kang, Jianming Lu, Alan T. Remaley, Valeria De Giorgi, Leonard N. Chen, Kamille West, Liang Cao
Summary: Several variants of SARS-CoV-2 have emerged, some of which are associated with increased transmission and severity. Analyses of COVID-19 convalescent and diagnostic cohorts show that RBD antibody levels can serve as a good surrogate for neutralization activities. Individuals vaccinated with mRNA vaccines have significantly higher RBD antibody levels and similar neutralization activities compared to those naturally infected. This suggests that mRNA vaccination may generate more neutralizing RBD antibodies than natural immunity.
SCIENTIFIC REPORTS
(2022)
Article
Oncology
Guillaume Joe Pegna, Min-Jung Lee, Cody J. Peer, Mehwish Ahmad, David J. Venzon, Yunkai Yu, Akira Yuno, Seth M. Steinberg, Liang Cao, William D. Figg, Renee N. Donahue, Raffit Hassan, Ira Pastan, Jane B. Trepel, Christine Alewine
Summary: The clinical trial of LMB-100 demonstrated some clinical efficacy but also revealed the potential intolerable side effect of capillary leak syndrome (CLS) when combined with nab-paclitaxel. Furthermore, LMB-100 treatment was found to cause systemic immune activation and associated inflammatory and immune changes.
Article
Hematology
Alexander H. Yang, Ma Ai Thanda Han, Niharika Samala, Bisharah S. Rizvi, Rachel Marchalik, Ohad Etzion, Elizabeth C. Wright, Liang Cao, Frances T. Hakim, Elizabeth Jones, Devika Kapuria, Dennis D. Hickstein, Daniel Fowler, Jennifer A. Kanakry, Christopher G. Kanakry, David E. Kleiner, Christopher Koh, Steven Z. Pavletic, Theo Heller
Summary: Hepatic chronic graft-versus-host disease (cGVHD) is difficult to diagnose accurately, and current diagnostic criteria lack specificity. This study aimed to characterize different patterns of liver injury and cytokine profiles associated with hepatic dysfunction in cGVHD, evaluate the accuracy of the NIH Consensus Criteria (NCC) for hepatic cGVHD, and explore predictors for hepatic cGVHD. The results showed that abnormal liver enzymes in cGVHD are nonspecific and have poor correlation with histologic evidence for hepatic GVHD, emphasizing the importance of histology. Additionally, decreased platelet count was associated with factors associated with liver disease, suggesting disease progression.
TRANSPLANTATION AND CELLULAR THERAPY
(2022)
Article
Oncology
Liang Cao, Yunkai Yu, Anish Thomas, Jingli Zhang, Masanori Onda, Paul Meltzer, Raffit Hassan, Ira Pastan
JCO PRECISION ONCOLOGY
(2018)
Article
Medical Laboratory Technology
Yunkai Yu, Brid M. Ryan, Anish Thomas, Betsy Morrow, Jingli Zhang, Zhigang Kang, Adriana Zingone, Masanori Onda, Raffit Hassan, Ira Pastan, Liang Cao
JOURNAL OF APPLIED LABORATORY MEDICINE
(2018)